| 000 | 01768 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250518005222.0 | ||
| 264 | 0 | _c20181217 | |
| 008 | 201812s 0 0 eng d | ||
| 022 | _a1471-2377 | ||
| 024 | 7 |
_a10.1186/s12883-018-1179-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDeftereos, Spyros N | |
| 245 | 0 | 0 |
_aSeasonal adherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational GEPAT-SMART study. _h[electronic resource] |
| 260 |
_bBMC neurology _cNov 2018 |
||
| 300 |
_a186 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aPersons with Disabilities |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGreece |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferon beta-1a _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultiple Sclerosis, Relapsing-Remitting _xdrug therapy |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aSeasons |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aKoutlas, Evangelos | |
| 700 | 1 | _aKoutsouraki, Efrosini | |
| 700 | 1 | _aKyritsis, Athanassios | |
| 700 | 1 | _aPapathanassopoulos, Panagiotis | |
| 700 | 1 | _aFakas, Nikolaos | |
| 700 | 1 | _aTsimourtou, Vaia | |
| 700 | 1 | _aVlaikidis, Nikolaos | |
| 700 | 1 | _aTavernarakis, Antonios | |
| 700 | 1 | _aVoumvourakis, Konstantinos | |
| 700 | 1 | _aArvanitis, Michalis | |
| 700 | 1 | _aSakellariou, Dimitrios | |
| 700 | 1 | _aDeLorenzo, Filippo | |
| 773 | 0 |
_tBMC neurology _gvol. 18 _gno. 1 _gp. 186 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12883-018-1179-0 _zAvailable from publisher's website |
| 999 |
_c29017166 _d29017166 |
||